Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis
ConclusionsFPC iron can be administered to pediatric patients with CKD-5HD via dialysate or by the IV route. Further study of FPC administered to maintain hemoglobin concentration is indicated.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Anemia | Chronic Kidney Disease | Dialysis | Hemodialysis | Iron | Pediatrics | Study | Urology & Nephrology